This company has shut down. scPharmaceuticals is no longer operating — its last tracked round was a Post-IPO Debt in 2024.
Explore the Startup GraveyardScPharmaceuticals is a biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.
scPharmaceuticals has raised $125.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in August 2024.
scPharmaceuticals's investors include Perceptive Advisors, OrbiMed, Oaktree Capital Management, 5AM Ventures, Sun Pharmaceutical.
scPharmaceuticals is headquartered in Lexington, United States.
ScPharmaceuticals is a biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.
scPharmaceuticals is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"scPharmaceuticals — Funding & Investors." VCBacked, August 12, 2024, https://www.vcbacked.co/company/scpharmaceuticals. Accessed September 6, 2026.
VCBacked. (2024). scPharmaceuticals — Funding & Investors. Retrieved September 6, 2026, from https://www.vcbacked.co/company/scpharmaceuticals
{{cite web |title=scPharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/scpharmaceuticals |website=VCBacked |access-date=September 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated